Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients

AUTOR(ES)

Osman, Emad-Aldin I., Hamad, Kamal, Elmula, Imad M. Fadl, Ibrahim, Muntaser E.

FONTE

Genetics and Molecular Biology

DATA DE PUBLICAÇÃO

30/04/2010

RESUMO

The incidence of one or other rearrangement in chronic myeloid leukemia (CML) patients varies in different reported series. In this study we report the frequencies of BCR-ABL1 fusion transcript variants studied in 43 CML patients from Sudan. The study includes 46 Sudanese patients, three of which negative for the BCR-ABL1 fusion transcript. More than half of 43 positive patients showed b2a2 fusion transcript (53.5%), while (41.9%) showed b3a2 transcript and the remaining (4.6%) coexpression of b3a2/ b2a2 and b3a2/b2a2/e19a2. We detected neither coexpression of p210/p190 nor e1a2 alone. Male patients showed a tendency to express b2a2, while female tende to express b3a2 (p = 0.017). Moreover, a single nucleotide polymorphism was detected in BCR exon 13 in one out of four patients and this patient showed only b2a2 expression. In conclusion, we observed a significant correlation between sex and type of BCR-ABL1 transcript, an observation that deserves further investigation.

Documentos Relacionados

• Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations
• BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil - not so real
• bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.
• Expression of bcr and bcr-abl fusion transcripts in normal and leukemic cells.
• Presence of the bcr/abl rearrangement in a patient with chronic neutrophilic leukaemia.